| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
í Plach
* Medical Policlinic,
Institute for Animal Physiology, and
Institute for Anatomy, University of Munich, Munich, Germany;
Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic; and
¶
GSF National Research Center for Environment and Health, Institute of Molecular Immunology, Munich, Germany
Chemokines play an important role in the recruitment of leukocytes and have recently been shown to also attract regulatory T cells. Using blocking mAbs, we analyzed the role of the chemokine receptor CCR2 during initiation and progression of collagen-induced arthritis in mice. Blockade of CCR2 from days 0 to 15 markedly improved clinical signs of arthritis and histological scores measuring leukocyte infiltration, synovial hyperplasia, and bone and cartilage erosion. CCR2 blockade during disease initiation significantly reduced plasma titers of collagen Abs in vivo. In vitro CCR2 blockade also interfered with collagen-specific activation and proliferation of T cells. Surprisingly, CCR2 blockade from days 21 to 36 markedly aggravated clinical and histological signs of arthritis and increased the humoral immune response against collagen. We show that CCR2 is expressed on regulatory T cells. Purified CCR2+ T cells are fully anergic toward polyclonal and collagen-specific activation and potently suppress activation of other T and B cells. The subpopulation of CCR2+ CD25+ regulatory T cells increases 
5-fold in the progression phase, while CCR2 expression on other leukocyte populations remains unchanged. These findings identify CCR2+ T cells as regulatory T cells and indicate that CCR2 also plays an important role in down-modulating an inflammatory response.
This article has been cited by other articles:
|
|
 |
|
  A. Mildner, M. Mack, H. Schmidt, W. Bruck, M. Djukic, M. D. Zabel, A. Hille, J. Priller, and M. Prinz CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system Brain, September 1, 2009; 132(9): 2487 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Webb, A. Johnson, M. Fortunato, A. Platt, T. Crabbe, M. I. Christie, G. F. Watt, S. G. Ward, and L. A. Jopling Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists J. Leukoc. Biol., October 1, 2008; 84(4): 1202 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Handel, Z. Johnson, D. H. Rodrigues, A. C. dos Santos, R. Cirillo, V. Muzio, S. Riva, M. Mack, M. Deruaz, F. Borlat, et al. An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo J. Leukoc. Biol., October 1, 2008; 84(4): 1101 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. T. Lau, S. Biester, R. J. Cornall, and J. V. Forrester Lipopolysaccharide-Activated IL-10-Secreting Dendritic Cells Suppress Experimental Autoimmune Uveoretinitis by MHCII-Dependent Activation of CD62L-Expressing Regulatory T Cells J. Immunol., March 15, 2008; 180(6): 3889 - 3899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shahrara, A. E. I. Proudfoot, C. C. Park, M. V. Volin, G. K. Haines, J. M. Woods, C. H. Aikens, T. M. Handel, and R. M. Pope Inhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis J. Immunol., March 1, 2008; 180(5): 3447 - 3456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Mohan and T. B. Issekutz Blockade of Chemokine Receptor CXCR3 Inhibits T Cell Recruitment to Inflamed Joints and Decreases the Severity of Adjuvant Arthritis J. Immunol., December 15, 2007; 179(12): 8463 - 8469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Behrens, A. Himsel, S. Rehart, J. Stanczyk, B. Beutel, S. Y Zimmermann, U. Koehl, B. Moller, S. Gay, J. P Kaltwasser, et al. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis Ann Rheum Dis, September 1, 2007; 66(9): 1151 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Schneider, J. G. Meingassner, M. Lipp, H. D. Moore, and A. Rot CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells J. Exp. Med., April 16, 2007; 204(4): 735 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Ellingsen, N Hornung, B K Moller, J H Poulsen, and K Stengaard-Pedersen Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders Ann Rheum Dis, February 1, 2007; 66(2): 151 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goser, M. Andrassy, S. J. Buss, F. Leuschner, C. H. Volz, R. Ottl;, S. Zittrich;, N. Blaudeck, S. E. Hardt, G. Pfitzer, et al. Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium Circulation, October 17, 2006; 114(16): 1693 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shahrara, C. C. Park, V. Temkin, J. W. Jarvis, M. V. Volin, and R. M. Pope RANTES Modulates TLR4-Induced Cytokine Secretion in Human Peripheral Blood Monocytes J. Immunol., October 15, 2006; 177(8): 5077 - 5087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cassan, E. Piaggio, J. P. Zappulla, L. T. Mars, N. Couturier, F. Bucciarelli, S. Desbois, J. Bauer, D. Gonzalez-Dunia, and R. S. Liblau Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells J. Immunol., August 1, 2006; 177(3): 1552 - 1560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wei, I. Kryczek, and W. Zou Regulatory T-cell compartmentalization and trafficking Blood, July 15, 2006; 108(2): 426 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goser, R. Ottl;, A. Brodner, T. J. Dengler, J. Torzewski, K. Egashira, N. R. Rose, H. A. Katus, and Z. Kaya Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1{alpha} in Induction of Experimental Autoimmune Myocarditis and Effective Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Circulation, November 29, 2005; 112(22): 3400 - 3407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Siegmund, M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schon, A. Scheffold, J. B. Lowe, et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo Blood, November 1, 2005; 106(9): 3097 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Terwey, T. D. Kim, A. A. Kochman, V. M. Hubbard, S. Lu, J. L. Zakrzewski, T. Ramirez-Montagut, J. M. Eng, S. J. Muriglan, G. Heller, et al. CCR2 is required for CD8-induced graft-versus-host disease Blood, November 1, 2005; 106(9): 3322 - 3330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Brodmerkel, R. Huber, M. Covington, S. Diamond, L. Hall, R. Collins, L. Leffet, K. Gallagher, P. Feldman, P. Collier, et al. Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344 J. Immunol., October 15, 2005; 175(8): 5370 - 5378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Valentonyte, J. Hampe, P. J. P. Croucher, J. Muller-Quernheim, E. Schwinger, S. Schreiber, and M. Schurmann Study of C-C Chemokine Receptor 2 Alleles in Sarcoidosis, with Emphasis on Family-based Analysis Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1136 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Guo, V. de Waard, M. Van Eck, R. B. Hildebrand, E. J.A. van Wanrooij, J. Kuiper, N. Maeda, G. M. Benson, P. H.E. Groot, and T. J.C. Van Berkel Repopulation of Apolipoprotein E Knockout Mice With CCR2-Deficient Bone Marrow Progenitor Cells Does Not Inhibit Ongoing Atherosclerotic Lesion Development Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 1014 - 1019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mack, M. A. Schneider, C. Moll, J. Cihak, H. Bruhl, J. W. Ellwart, M. P. Hogarth, M. Stangassinger, and D. Schlondorff Identification of Antigen-Capturing Cells as Basophils J. Immunol., January 15, 2005; 174(2): 735 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Anders, V. Vielhauer, and D. Schlondorff Current paradigms about chemokines as therapeutic targets Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2948 - 2951. [Full Text] [PDF]
|
|
|
|
|
|
T. Nanki, Y. Urasaki, T. Imai, M. Nishimura, K. Muramoto, T. Kubota, and N. Miyasaka Inhibition of Fractalkine Ameliorates Murine Collagen-Induced Arthritis J. Immunol., December 1, 2004; 173(11): 7010 - 7016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Herman, G. J. Freeman, D. Mathis, and C. Benoist CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion J. Exp. Med., June 7, 2004; 199(11): 1479 - 1489. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
